Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms

The Australian and New Zealand Journal of Psychiatry
Marise MachielsenLieuwe de Haan

Abstract

Co-morbidity with cannabis use disorder is common in patients with a psychotic disorder and is associated with adverse outcome. This study aimed to determine prevalence of cannabis use disorder among patients with a psychotic disorder and subjects at ultra high risk of psychosis and to study the influence of cannabis use on severity of (pre-)psychotic symptomatology, psychosocial functioning and variables related to the course of the disorder in these patients. In this study 169 consecutively assessed patients with a psychotic disorder were included as well as 59 consecutively assessed subjects at ultra high risk of psychosis. 45% of the patients with a psychotic disorder and 27% of the UHR patients were diagnosed with a co-morbid cannabis use disorder. Patients with cannabis use disorders did not differ from patients without cannabis use disorder in severity of psychotic symptoms. However, excluding patients with substance use disorder other than cannabis use disorder resulted in higher scores on positive symptom levels for patients with cannabis use disorder compared to patients without any substance use disorder. Regarding ultra high risk patients, subjects with cannabis use disorder did not differ from subjects without cann...Continue Reading

References

Feb 1, 1992·Acta Psychiatrica Scandinavica·V Peralta, M J Cuesta
Nov 21, 1990·JAMA : the Journal of the American Medical Association·D A RegierF K Goodwin
Jan 1, 1990·Schizophrenia Bulletin·K T MueserK G Yadalam
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Apr 1, 1994·Archives of General Psychiatry·D H LinszenM E Lenior
May 1, 1996·Schizophrenia Research·B KirkpatrickT McGlashan
Apr 9, 1999·European Archives of Psychiatry and Clinical Neuroscience·D Caspari
Jul 6, 2000·The Australian and New Zealand Journal of Psychiatry·M Hambrecht, H Häfner
Jul 12, 2002·European Archives of Psychiatry and Clinical Neuroscience·G BersaniP Pancheri
Oct 31, 2002·The Australian and New Zealand Journal of Psychiatry·Lisa J PhillipsPatrick D McGorry
Dec 31, 2002·Schizophrenia Research·Alison R YungPatrick D McGorry
Apr 16, 2003·Schizophrenia Bulletin·Geraldine Scheller-GilkeyAndrew H Miller
Feb 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Louise ArseneaultRobin M Murray
Oct 4, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Bob GreenDavid Kavanagh
Apr 14, 2006·Current Opinion in Psychiatry·Jagadisha Thirthalli, Vivek Benegal
Mar 27, 2007·Psychiatry Research·Karin Kristensen, Kristin S Cadenhead
Nov 4, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Stanley ZammitGlyn Lewis
Apr 21, 2009·Comprehensive Psychiatry·Matthew J SmithLinda B Cottler

❮ Previous
Next ❯

Citations

Jul 19, 2013·Schizophrenia Bulletin·Orwa DandashBen J Harrison
Oct 30, 2015·Journal of Dual Diagnosis·Belen ArranzLuis San
Aug 22, 2012·Acta Psychiatrica Scandinavica·N OkkelsR E Nielsen
Nov 28, 2013·Early Intervention in Psychiatry·Kelly E GillCheryl M Corcoran
Mar 3, 2015·Psychological Medicine·L BuchyJ Addington
Sep 28, 2014·Schizophrenia Research·Jack CotterAlison R Yung
Sep 7, 2016·Early Intervention in Psychiatry·Kellie L HaddenBarbara Thomas
Aug 20, 2015·The Australian and New Zealand Journal of Psychiatry·Hannah MylesMatthew Large
Mar 1, 2012·The Australian and New Zealand Journal of Psychiatry·Katherine MullinMatthew Large
Jul 20, 2011·Journal of Psychopharmacology·Marise MachielsenInez Myin-Germeys
Oct 29, 2015·The Cochrane Database of Systematic Reviews·Stefan LeuchtJohn J McGrath
Nov 7, 2019·The Cochrane Database of Systematic Reviews·Dina Bosnjak KuharicLivia Puljak
Dec 5, 2019·Social Psychiatry and Psychiatric Epidemiology·Megan S FarrisJean Addington
Jun 17, 2011·The Cochrane Database of Systematic Reviews·John BolaHaluk Soydan
Jan 19, 2013·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Stephen J WoodKareen Heinze
Mar 28, 2012·Current Opinion in Psychiatry·Neo K MorojeleSoraya Seedat
Jul 20, 2021·The American Journal of Drug and Alcohol Abuse·Karolina KozakTony P George

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved